146 related articles for article (PubMed ID: 22507909)
1. Ex vivo alloanergization with belatacept: a strategy to selectively modulate alloresponses after transplantation.
Davies JK; Barbon CM; Voskertchian A; Nadler LM; Guinan EC
Cell Transplant; 2012; 21(9):2047-61. PubMed ID: 22507909
[TBL] [Abstract][Full Text] [Related]
2. Induction of alloantigen-specific anergy in human peripheral blood mononuclear cells by alloantigen stimulation with co-stimulatory signal blockade.
Davies JK; Barbon CM; Voskertchian AR; Nadler LM; Guinan EC
J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445041
[TBL] [Abstract][Full Text] [Related]
3. Alloanergization of human T cells results in expansion of alloantigen-specific CD8(+) CD28(-) suppressor cells.
Barbon CM; Davies JK; Voskertchian A; Kelner RH; Brennan LL; Nadler LM; Guinan EC
Am J Transplant; 2014 Feb; 14(2):305-18. PubMed ID: 24410845
[TBL] [Abstract][Full Text] [Related]
4. Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity.
Davies JK; Yuk D; Nadler LM; Guinan EC
Transplantation; 2008 Sep; 86(6):854-64. PubMed ID: 18813111
[TBL] [Abstract][Full Text] [Related]
5. Alloanergization Method for Inducing Allospecific Hyporesponsiveness in PBMC Exposed to Allostimulation In Vitro in the Context of Costimulatory Molecule Blockade.
Barbon CM; Janec KJ; Kelner RH; Norton JE; Guinan EC
Methods Mol Biol; 2019; 1899():103-118. PubMed ID: 30649768
[TBL] [Abstract][Full Text] [Related]
6. Allospecific Tregs Expanded After Anergization Remain Suppressive in Inflammatory Conditions but Lack Expression of Gut-homing Molecules.
Kotsiou E; Gribben JG; Davies JK
Mol Ther; 2016 Jun; 24(6):1126-1134. PubMed ID: 27049761
[TBL] [Abstract][Full Text] [Related]
7. Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responses.
Comoli P; Locatelli F; Moretta A; Montagna D; Calcaterra V; Cometa A; Basso S; Zecca M; Maccario R
Bone Marrow Transplant; 2001 Jun; 27(12):1263-73. PubMed ID: 11548844
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of Belatacept on virus-specific memory versus de novo allo-specific T cell responses of kidney transplant recipients and healthy donors.
Kühne JF; Neudörfl C; Beushausen K; Keil J; Malysheva S; Wandrer F; Haller H; Messerle M; Blume C; Neuenhahn M; Schlott F; Hammerschmidt W; Zeidler R; Falk CS
Transpl Immunol; 2020 Aug; 61():101291. PubMed ID: 32330566
[TBL] [Abstract][Full Text] [Related]
9. Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade.
Chavez H; Beaudreuil S; Abbed K; Taoufic Y; Kriaa F; Charpentier B; Durrbach A
Transpl Immunol; 2007 Jun; 17(4):243-8. PubMed ID: 17493526
[TBL] [Abstract][Full Text] [Related]
10. Ex Vivo Generation of Donor Antigen-Specific Immunomodulatory Cells: A Comparison Study of Anti-CD80/86 mAbs and CTLA4-lg Costimulatory Blockade.
Watanabe M; Kumagai-Braesch M; Yao M; Thunberg S; Berglund D; Sellberg F; Jorns C; Enoksson SL; Henriksson J; Lundgren T; Uhlin M; Berglund E; Ericzon BG
Cell Transplant; 2018 Nov; 27(11):1692-1704. PubMed ID: 30261751
[TBL] [Abstract][Full Text] [Related]
11. The Immunosuppressive Effect of CTLA4 Immunoglobulin Is Dependent on Regulatory T Cells at Low But Not High Doses.
Schwarz C; Unger L; Mahr B; Aumayr K; Regele H; Farkas AM; Hock K; Pilat N; Wekerle T
Am J Transplant; 2016 Dec; 16(12):3404-3415. PubMed ID: 27184870
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation.
Chen Y; Fukuda T; Thakar MS; Kornblit BT; Storer BE; Santos EB; Storb R; Sandmaier BM
Cytotherapy; 2011 Nov; 13(10):1269-80. PubMed ID: 21846291
[TBL] [Abstract][Full Text] [Related]
13. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.
Arpinati M; Terragna C; Chirumbolo G; Rizzi S; Urbini B; Re F; Tura S; Baccarani M; Rondelli D
Exp Hematol; 2003 Jan; 31(1):31-8. PubMed ID: 12543104
[TBL] [Abstract][Full Text] [Related]
14. Ex Vivo Costimulatory Blockade to Generate Regulatory T Cells From Patients Awaiting Kidney Transplantation.
Guinan EC; Cole GA; Wylie WH; Kelner RH; Janec KJ; Yuan H; Oppatt J; Brennan LL; Turka LA; Markmann J
Am J Transplant; 2016 Jul; 16(7):2187-95. PubMed ID: 26790369
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Development of Transplant Arteriosclerosis in Humanized Mice Reflects Alloantigen Recognition and Peripheral Treg Phenotype of Lung Transplant Recipients.
Siemeni T; Knöfel AK; Madrahimov N; Sommer W; Avsar M; Salman J; Ius F; Frank N; Büchler G; Jonigk D; Jansson K; Maus U; Tudorache I; Falk CS; Haverich A; Warnecke G
Am J Transplant; 2016 Nov; 16(11):3150-3162. PubMed ID: 27273729
[TBL] [Abstract][Full Text] [Related]
16. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
17. Prolonged, low-dose anti-thymocyte globulin, combined with CTLA4-Ig, promotes engraftment in a stringent transplant model.
D'Addio F; Boenisch O; Magee CN; Yeung MY; Yuan X; Mfarrej B; Vergani A; Ansari MJ; Fiorina P; Najafian N
PLoS One; 2013; 8(1):e53797. PubMed ID: 23326509
[TBL] [Abstract][Full Text] [Related]
18. B7/CTLA4 pathway is essential for generating regulatory cells after intratracheal delivery of alloantigen in mice.
Akiyama Y; Shirasugi N; Uchida N; Matsumoto K; Kitajima M; Bashuda H; Yagita H; Okumura K; Aramaki O; Niimi M
Transplantation; 2002 Sep; 74(5):732-8. PubMed ID: 12352894
[TBL] [Abstract][Full Text] [Related]
19. The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman Primates.
Oshima S; Karrer EE; Kawato Y; Maeda M; Fukahori H; Tsujimoto S; Hirose J; Nakamura K; Marui T; Takamura F; Noto T; Chapin SJ; Fujii Y; Neighbors M; Viswanathan S; Devens BH; Higashi Y
Transplantation; 2016 Dec; 100(12):2611-2620. PubMed ID: 27861289
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans.
Levitsky J; Miller J; Huang X; Chandrasekaran D; Chen L; Mathew JM
Transplantation; 2013 Oct; 96(8):689-96. PubMed ID: 23883971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
